Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function
Myung-Hoon Han, Eun-Hye Lee, Seong-Ho Koh
Int Neurourol J. 2016;20(4):276-287.   Published online 2016 Dec 26     DOI: https://doi.org/10.5213/inj.1632776.388
Citations to this article as recorded by Crossref logo
Pharmacological activation of the Nrf2 pathway by 3H-1, 2-dithiole-3-thione is neuroprotective in a mouse model of Alzheimer disease
YuanBo Cui, ShanShan Ma, ChunYan Zhang, DongPeng Li, Bo Yang, PengJu Lv, Qu Xing, Tuanjie Huang, Greta Luyuan Yang, Wei Cao, FangXia Guan
Behavioural Brain Research.2018; 336: 219.     CrossRef
Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review
Zhiwei Shen, Xueyuan Li, Xinjie Bao, Renzhi Wang
Journal of Neuroscience Research.2017; 95(12): 2420.     CrossRef
Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer’s Disease
Shuying Dong, Shelly Maniar, Mioara D. Manole, Dandan Sun
Translational Stroke Research.2017;[Epub]     CrossRef
Potential for stem cell treatment in manganism
Thatiane C. de Moura, Szeifoul Afadlal, Alan S. Hazell
Neurochemistry International.2017;[Epub]     CrossRef
Neurourological Application of Neurogenesis and Inflammation and Pain Mechanisms of Rocuronium Bromide
Khae Hawn Kim
International Neurourology Journal.2016; 20(4): 274.     CrossRef